PARAGARD T380A Rx
Generic Name and Formulations:
Copper-bearing intrauterine contraceptive device.
The Cooper Companies
Indications for PARAGARD T380A:
See literature. ≥16yrs: Insert into uterine cavity. Check placement shortly after first menses. Replace at least every 10 years.
<16yrs: not recommended.
Uterine abnormality. Uterine or cervical malignancy. Pelvic inflammatory disease or risk thereof. Postpartum or postabortal endometritis in the past 3 months. Genital actinomycosis. Abnormal genital bleeding. Cervicitis. Wilson's disease. Retained IUD. Pregnancy or suspicion of pregnancy.
Vaginal bleeding. Ectopic pregnancy. Immunocompromised. Immunosuppressive therapy. Avoid medical diathermy. Assure suitable uterine anatomy before insertion. Remove the device if evidence of partial expulsion, perforation, or breakage.
Bleeding, cramps, anemia, dyspareunia, pelvic infection, infertility, ectopic pregnancy, uterine or cervical perforation, embedment or fragmentation of device, septicemia (during pregnancy), spontaneous abortion, vasovagal reactions (during insertion or removal).
Endocrinology Advisor Articles
- Diabetic Retinopathy Risk Not Increased With GLP-1 Receptor Agonist Use in T2D
- Concurrent Risk Factors and Microvascular Complications in Type 1 Diabetes
- Higher Risk for Meningioma Linked to GH Treatment, Radiotherapy During Childhood
- Early Treatment Intensification and Faster Glycemic Control in T2D
- Comparing Antidiabetic Drug Classes for Risk of Heart Failure
- Nutraceuticals May Benefit Patients Who Are Statin Intolerant
- Hypertension Treatments: ARBs
- Semaglutide vs Liraglutide for Weight Loss in Patients With Obesity
- Liraglutide May Lower Risk for Foot Amputation in Type 2 Diabetes
- Thyroid Hormone Levels, Body Composition, Insulin Resistance in Euthyroid Patients
- Behavioral Weight Loss Interventions May Prevent Obesity
- Disaster Preparedness 101: Physician Resources for Patients
- Assessing the Environmental Impact of the Healthcare Industry
- Medical Schools Phase Out Lectures as Education Shifts Outside the Classroom
- Clonidine Testing Is Safe and Reliable for Diagnosing Growth Hormone Deficiency